Cargando…
Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791920/ https://www.ncbi.nlm.nih.gov/pubmed/24106420 http://dx.doi.org/10.2147/DDDT.S43035 |
_version_ | 1782286772475002880 |
---|---|
author | Dorniani, Dena Hussein, Mohd Zobir bin Kura, Aminu Umar Fakurazi, Sharida Shaari, Abdul Halim Ahmad, Zalinah |
author_facet | Dorniani, Dena Hussein, Mohd Zobir bin Kura, Aminu Umar Fakurazi, Sharida Shaari, Abdul Halim Ahmad, Zalinah |
author_sort | Dorniani, Dena |
collection | PubMed |
description | BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types of drugs. METHODS AND RESULTS: We synthesized superparamagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. Fourier transform infrared spectra confirmed that these Fe(3)O(4) nanoparticles could be successfully coated with active drug, and thermogravimetric and differential thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The synthesized Fe(3)O(4) nanoparticles and the FCMP nanocomposite were generally spherical, with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. In order to improve drug loading and release behavior, we prepared a novel nanocomposite (FCMP-D), ie, Fe(3)O(4) nanoparticles containing the same amounts of chitosan and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did not demonstrate “burst release” and the maximum percentage release of 6-mercaptopurine from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse fibroblast cell line. CONCLUSION: Iron oxide coated with chitosan containing 6-mercaptopurine prepared using a coprecipitation method has the potential to be used as a controlled-release formulation. These nanoparticles may serve as an alternative drug delivery system for the treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue. |
format | Online Article Text |
id | pubmed-3791920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-37919202013-10-08 Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system Dorniani, Dena Hussein, Mohd Zobir bin Kura, Aminu Umar Fakurazi, Sharida Shaari, Abdul Halim Ahmad, Zalinah Drug Des Devel Ther Original Research BACKGROUND: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types of drugs. METHODS AND RESULTS: We synthesized superparamagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. Fourier transform infrared spectra confirmed that these Fe(3)O(4) nanoparticles could be successfully coated with active drug, and thermogravimetric and differential thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The synthesized Fe(3)O(4) nanoparticles and the FCMP nanocomposite were generally spherical, with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. In order to improve drug loading and release behavior, we prepared a novel nanocomposite (FCMP-D), ie, Fe(3)O(4) nanoparticles containing the same amounts of chitosan and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did not demonstrate “burst release” and the maximum percentage release of 6-mercaptopurine from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse fibroblast cell line. CONCLUSION: Iron oxide coated with chitosan containing 6-mercaptopurine prepared using a coprecipitation method has the potential to be used as a controlled-release formulation. These nanoparticles may serve as an alternative drug delivery system for the treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue. Dove Medical Press 2013-09-25 /pmc/articles/PMC3791920/ /pubmed/24106420 http://dx.doi.org/10.2147/DDDT.S43035 Text en © 2013 Dorniani et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Dorniani, Dena Hussein, Mohd Zobir bin Kura, Aminu Umar Fakurazi, Sharida Shaari, Abdul Halim Ahmad, Zalinah Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title | Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title_full | Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title_fullStr | Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title_full_unstemmed | Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title_short | Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
title_sort | preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791920/ https://www.ncbi.nlm.nih.gov/pubmed/24106420 http://dx.doi.org/10.2147/DDDT.S43035 |
work_keys_str_mv | AT dornianidena preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem AT husseinmohdzobirbin preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem AT kuraaminuumar preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem AT fakurazisharida preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem AT shaariabdulhalim preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem AT ahmadzalinah preparationandcharacterizationof6mercaptopurinecoatedmagnetitenanoparticlesasadrugdeliverysystem |